share_log

Exelixis Analyst Ratings

Exelixis Analyst Ratings

Exelixis 分析师评级
Benzinga Analyst Ratings ·  2023/02/08 08:24
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/08/2023 38.81% EF Hutton → $24 Reiterates → Buy
01/26/2023 67.73% Credit Suisse → $29 Initiates Coverage On → Outperform
01/19/2023 38.81% JMP Securities $25 → $24 Maintains Market Outperform
01/11/2023 38.81% EF Hutton $28 → $24 Maintains Buy
12/09/2022 44.59% JMP Securities $26 → $25 Maintains Market Outperform
11/02/2022 67.73% RBC Capital $31 → $29 Maintains Outperform
11/02/2022 27.24% Morgan Stanley $23 → $22 Maintains Equal-Weight
11/01/2022 61.94% EF Hutton → $28 Initiates Coverage On → Buy
10/18/2022 50.38% JMP Securities → $26 Initiates Coverage On → Market Outperform
07/26/2022 85.08% Piper Sandler $30 → $32 Maintains Overweight
07/15/2022 33.02% Morgan Stanley $22 → $23 Maintains Equal-Weight
06/24/2022 61.94% BMO Capital → $28 Initiates Coverage On → Outperform
02/18/2022 142.91% HC Wainwright & Co. $52 → $42 Maintains Buy
11/03/2021 79.29% RBC Capital $32 → $31 Maintains Outperform
11/03/2021 200.75% HC Wainwright & Co. $65 → $52 Maintains Buy
11/02/2021 67.73% Oppenheimer $30 → $29 Maintains Outperform
10/07/2021 61.94% Jefferies → $28 Initiates Coverage On → Buy
09/20/2021 108.21% Truist Securities $37 → $36 Maintains Buy
06/28/2021 73.51% Needham $33 → $30 Maintains Buy
06/15/2021 171.83% HC Wainwright & Co. → $47 Initiates Coverage On → Buy
04/19/2021 50.38% Morgan Stanley $27 → $26 Maintains Equal-Weight
03/31/2021 73.51% Credit Suisse → $30 Initiates Coverage On → Outperform
03/12/2021 102.43% Wolfe Research → $35 Initiates Coverage On → Outperform
02/16/2021 108.21% Piper Sandler $33 → $36 Maintains Overweight
12/16/2020 56.16% Morgan Stanley $29 → $27 Maintains Equal-Weight
10/26/2020 56.16% Stifel $26 → $27 Maintains Hold
09/22/2020 67.73% Morgan Stanley $23 → $29 Maintains Equal-Weight
09/21/2020 90.86% Piper Sandler $30 → $33 Maintains Overweight
09/21/2020 114% Oppenheimer $33 → $37 Maintains Outperform
08/07/2020 33.02% Morgan Stanley $22 → $23 Maintains Equal-Weight
07/15/2020 27.24% Morgan Stanley $21 → $22 Maintains Equal-Weight
06/01/2020 85.08% Oppenheimer $28 → $32 Maintains Outperform
05/14/2020 131.35% SunTrust Robinson Humphrey $35 → $40 Maintains Buy
05/06/2020 56.16% BMO Capital $20 → $27 Maintains Market Perform
05/06/2020 21.46% Morgan Stanley $20 → $21 Maintains Equal-Weight
04/21/2020 61.94% Oppenheimer $25 → $28 Maintains Outperform
04/20/2020 90.86% Needham $28 → $33 Maintains Buy
03/04/2020 50.38% Barclays → $26 Initiates Coverage On → Overweight
02/26/2020 33.02% Stifel $21 → $23 Maintains Hold
02/26/2020 15.67% BMO Capital $19 → $20 Maintains Market Perform
01/13/2020 79.29% SunTrust Robinson Humphrey → $31 Initiates Coverage On → Buy
01/13/2020 21.46% B of A Securities $22 → $21 Reiterates → Buy
10/15/2019 44.59% Guggenheim $33 → $25 Maintains Buy
10/08/2019 9.89% BMO Capital $23 → $19 Maintains Market Perform
08/01/2019 33.02% Stifel $22 → $23 Maintains Hold
03/18/2019 — Morgan Stanley Upgrades Underweight → Equal-Weight
02/22/2019 33.02% BMO Capital → $23 Initiates Coverage On → Market Perform
09/17/2018 27.24% Goldman Sachs → $22 Initiates Coverage On → Neutral
09/10/2018 9.89% Morgan Stanley → $19 Initiates Coverage On → Underweight
08/01/2018 44.59% Stifel $29 → $25 Maintains Hold
05/03/2018 67.73% Stifel $30 → $29 Maintains Hold
02/27/2018 73.51% Stifel $29 → $30 Maintains Hold
02/27/2018 — Oppenheimer Upgrades Perform → Outperform
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
02/08/2023 38.81% EF Hutton → $24 重申 →购买
01/26/2023 67.73% 瑞士信贷 → $29 开始承保 →跑赢大盘
01/19/2023 38.81% JMP证券 $25 → $24 维护 市场表现强于大盘
01/11/2023 38.81% EF Hutton $28 → $24 维护 买
12/09/2022 44.59% JMP证券 $26 → $25 维护 市场表现强于大盘
11/02/2022 67.73% 加拿大皇家银行资本 $31 → $29 维护 跑赢大盘
11/02/2022 27.24% 摩根士丹利 $23 → $22 维护 等重
11/01/2022 61.94% EF Hutton → $28 开始承保 →购买
10/18/2022 50.38% JMP证券 → $26 开始承保 →市场跑赢大盘
07/26/2022 85.08% 派珀·桑德勒 $30 → $32 维护 超重
07/15/2022 33.02% 摩根士丹利 $22 → $23 维护 等重
06/24/2022 61.94% 蒙特利尔银行资本 → $28 开始承保 →跑赢大盘
02/18/2022 142.91% HC Wainwright公司 $52 → $42 维护 买
11/03/2021 79.29% 加拿大皇家银行资本 $32 → $31 维护 跑赢大盘
11/03/2021 200.75% HC Wainwright公司 $65 → $52 维护 买
11/02/2021 67.73% 奥本海默 $30 → $29 维护 跑赢大盘
10/07/2021 61.94% 杰富瑞 → $28 开始承保 →购买
09/20/2021 108.21% Truist证券 $37 → $36 维护 买
06/28/2021 73.51% 李约瑟 $33 → $30 维护 买
06/15/2021 171.83% HC Wainwright公司 → $47 开始承保 →购买
04/19/2021 50.38% 摩根士丹利 $27 → $26 维护 等重
03/31/2021 73.51% 瑞士信贷 → $30 开始承保 →跑赢大盘
03/12/2021 102.43% 沃尔夫研究 → $35 开始承保 →跑赢大盘
02/16/2021 108.21% 派珀·桑德勒 $33 → $36 维护 超重
12/16/2020 56.16% 摩根士丹利 $29 → $27 维护 等重
10/26/2020 56.16% Stifel $26 → $27 维护 保持
09/22/2020 67.73% 摩根士丹利 $23 → $29 维护 等重
09/21/2020 90.86% 派珀·桑德勒 $30 → $33 维护 超重
09/21/2020 114% 奥本海默 $33 → $37 维护 跑赢大盘
08/07/2020 33.02% 摩根士丹利 $22 → $23 维护 等重
07/15/2020 27.24% 摩根士丹利 $21 → $22 维护 等重
06/01/2020 85.08% 奥本海默 $28 → $32 维护 跑赢大盘
05/14/2020 131.35% SunTrust Robinson Humphrey $35 → $40 维护 买
05/06/2020 56.16% 蒙特利尔银行资本 $20 → $27 维护 市场表现
05/06/2020 21.46% 摩根士丹利 $20 → $21 维护 等重
04/21/2020 61.94% 奥本海默 $25 → $28 维护 跑赢大盘
04/20/2020 90.86% 李约瑟 $28 → $33 维护 买
03/04/2020 50.38% 巴克莱 → $26 开始承保 →超重
02/26/2020 33.02% Stifel $21 → $23 维护 保持
02/26/2020 15.67% 蒙特利尔银行资本 $19 → $20 维护 市场表现
01/13/2020 79.29% SunTrust Robinson Humphrey → $31 开始承保 →购买
01/13/2020 21.46% B of A证券 $22 → $21 重申 →购买
10/15/2019 44.59% 古根海姆 $33 → $25 维护 买
10/08/2019 9.89% 蒙特利尔银行资本 $23 → $19 维护 市场表现
08/01/2019 33.02% Stifel $22 → $23 维护 保持
03/18/2019 — 摩根士丹利 升级 重量不足的→等重
02/22/2019 33.02% 蒙特利尔银行资本 → $23 开始承保 →市场表现
09/17/2018 27.24% 高盛 → $22 开始承保 →中性
09/10/2018 9.89% 摩根士丹利 → $19 开始承保 →减持
08/01/2018 44.59% Stifel $29 → $25 维护 保持
05/03/2018 67.73% Stifel $30 → $29 维护 保持
02/27/2018 73.51% Stifel $29 → $30 维护 保持
02/27/2018 — 奥本海默 升级 →表现强于大盘

What is the target price for Exelixis (EXEL)?

Exelixis(Exel)的目标价格是多少？

The latest price target for Exelixis (NASDAQ: EXEL) was reported by EF Hutton on February 8, 2023. The analyst firm set a price target for $24.00 expecting EXEL to rise to within 12 months (a possible 38.81% upside). 13 analyst firms have reported ratings in the last year.

Exelixis(纳斯达克：EXEL)的最新目标价是由EF Hutton于2023年2月8日报道的。这家分析公司将目标价定为24美元，预计Exel将在12个月内上涨(可能上涨38.81%)。过去一年，有13家分析公司公布了评级。

What is the most recent analyst rating for Exelixis (EXEL)?

分析师对Exelixis(Exel)的最新评级是多少？

The latest analyst rating for Exelixis (NASDAQ: EXEL) was provided by EF Hutton, and Exelixis reiterated their buy rating.

对Exelixis(纳斯达克代码：EXEL)的最新分析师评级由EF Hutton提供，Exelixis重申其买入评级。

When is the next analyst rating going to be posted or updated for Exelixis (EXEL)?

Exelixis(Exel)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on February 8, 2023 so you should expect the next rating to be made available sometime around February 8, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Exelixis的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Exelixis的上一次评级是在2023年2月8日提交的，所以你应该预计下一次评级将在2024年2月8日左右提供。

Is the Analyst Rating Exelixis (EXEL) correct?

分析师评级Exelixis(Exel)正确吗？

While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a reiterated with a price target of $0.00 to $24.00. The current price Exelixis (EXEL) is trading at is $17.29, which is within the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Exelixis(Exel)评级被重申，目标价在0.00美元至24.00美元之间。Exelixis(Exel)目前的交易价格为17.29美元，在分析师的预测区间内。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发